Elderly controls and probable Alzheimer's disease patients underwent serial positron emission to mography (PET) studies during a baseline condition and while performing a verbal memory task. For the temporal lobes, all 7 Alzheimer patients demonstrated a relative shift in glucose metabolic rates to the right hemisphere during the memory condition relative to baseline, and 5 of 7 controls showed a shift to the left hemisphere. Base-Abbreviations used: llC-2DG, llC-2-deoxy-n-glucose; GDS, Global Deterioration Scale; MANOVA, multivariate analysis of variance; PET, positron emission tomography; ROI, region of interest.
Memory deficit is the behavioral hallmark of Alzheimer's disease and has been consistently as sociated with marked neuropathology of the tem poral lobes (Hyman et aI., 1984) . The general re duction in glucose metabolic rates in the brains of Alzheimer patients demonstrated by positron emis sion tomography (PET) during resting baseline studies (Ferris et aI., 1980) appears to be most prominent in the temporal and parietal cortices (Chase et aI., 1983; de Leon et aI., 1983; Friedland et aI., 1985) . Furthermore, these reductions in met abolic rates have been found to be associated with measures of behavioral deficit taken at other times. Until now, the effects on regional metabolism of be havioral perturbations during PET tracer uptake in Alzheimer patients have not been studied. We re port the first demonstration of a relationship be-line absolute regional metabolic rates replicate previous findings and were somewhat less useful than the memory challenge in differentiating patients from controls. These results indicate that a temporal lobe abnormality in Alz heimer's disease is related to memory performance. Key Words: Alzheimer's disease-Cerebral activation-llC-2-deoxy-n-glucose-Glucose metabolic rate asymme tries-Positron emission tomography-Te mporal lobes.
tween changes in temporal lobe activity and simul taneous memory deficit in clinically diagnosed Alz heimer's disease.
MATERIALS AND METHODS
All subjects received extensive medical, neurologic, psychiatric, neuropsychologic, neuroradiologic, and clin ical laboratory examinations to rule out clinically signifi cant medical and neurologic conditions and by exclusion to establish the clinical diagnosis of Alzheimer's disease for patients with dementia. Subjects with histories or physical evidence of stroke, psychiatric illness, head trauma, and alcohol or drug abuse were also excluded. Furthermore, no individuals requiring medication other than diuretics were accepted, nor were individuals ac cepted whose examinations revealed significant and un stable cardiovascular disease, diabetes (not controlled by diet alone), thyroid, or other metabolic dysfunctions. All subjects were right-handed. The 7-point Global Deterio ration Scale (GDS) (Reisberg et aI., 1982) was used to characterize overall cognitive impairment. Subjects whose GDS scores ranged between 3 and 6 were classi fied as mild to moderately severe Alzheimer's disease (mean age 68 ± 5.6, range 59-74, n = 7). Subjects with GDS scores of 1 or 2 may have had subjective com plaints, but were without objective evidence for cognitive impairment on either clinical interview or the Guild Memory Test (Gilbert and Levee, 197 1) and were classi fied as controls (mean age 67 ± 7.6, range 54-76, n = 7).
Counterbalanced serial PET studies (2 h apart) were conducted using lIC-2-deoxY-D-glucose (lIC-2DG) (tv> [lIC] = 20.4 min) under a baseline condition and while performing a verbal memory task. During the baseline study, subjects rested quietly under dim lighting with their eyes open and ears unplugged. The recognition memory study, conducted under the same conditions, consisted of grocery items presented one word every 5 s on a computer screen. Approximately half the words were repeated once, either immediately or following varying time delays of up to 8 min. The subject pressed one of two response buttons with the right index or middle finger, depending on whether or not the word was remembered as seen previously. An intravenous bolus of 6-8 mCi of lIC-2DG (MacGregor et aI., 1981) was given 35 min before scanning with the PETT VI scanner (Ter Pogossian et aI., 1982) and 2 min after the initiation of the memory task. The intrinsic spatial resolution of the PETT VI scanner is 1.2 x 1.2 x 1.4 cm at full-width half-maximum. Blood activity time curves were derived using arterialized venous blood. Two PET slices, one that best represented the basal ganglia level and one that was judged to best represent the centrum semiovale level, were selected for analysis from both the baseline and memory conditions. Scan slices were taken parallel to the canthomeatal plane (CM) and were 14 mm thick. Within 6 months of the PET study, each subject also had a com puted tomography (CT) scan taken parallel to the CM plane using a GE 8800 or GE 9800 CT scanner. CT slices were chosen that matched the selected PET slices. A specially designed computer graphics system displayed the PET and matching CT image side by side, compa rably aligned the images, and allowed the interactive translation of CT anatomy outlines onto the PET image. Regions of interest (ROIs) on the PET scan were thus defined using CT anatomy. Bilateral frontal, temporal, and thalamic ROIs were taken from the basal ganglia sec tion. The wedge-shaped frontal samples included most of the frontal lobe anterior to the frontal horns. Te mporal ROIs were crescent shaped, included a small portion of the superior temporal gyrus, and continued posteriorly to include the inferior temporal gyrus. Medially, this ROI excluded the atrium of the lateral ventricles. Sensori motor cortex and posterior parietal lobe samples were taken from the centrum semiovale section. The sensori motor sample extended approximately 1.5 cm anterior and 1.5 cm posterior to the central sulcus and was ap proximately 1.2 cm wide. The parietal lobe sample was approximately 2.0 cm long by 1.2 cm wide and was taken in the area of the angular gyrus. Right and left hemi spheric ROIs, both corrected for ventricle, were obtained from the basal ganglia slice.
RESULTS
All subjects responded to the memory trials, with controls responding to between 96% and 100% of the items (mean 99%) and the patients responding to between 53% to 97% (mean 72%). Ta sk perfor mance was estimated using a discrimination index (proportion of hits -proportion of false alarms). The mean discrimination index of the controls was 0.73 (range 0.55-0.88) and 0 for the patients (range -0.04-0). The patients then, as a group, re-sponded to most trials, but performed at a chance level.
The results for the baseline condition indicated significant diminutions in glucose metabolic rates (fLmolll00 g/min) for the set of 6 averaged homolo gous right and left ROls in the demented subjects, when compared to controls, using a one-way multi variate analysis of variance (F(6,7) = 4.05, p < 0.05). Post-hoc univariate F tests showed that the individual regions affected significantly (p < 0.05) by the disease were the averaged right and left hemispheres (-19%) and the averaged frontal (-22%), averaged parietal (-27%), and averaged temporal lobes (-27%), Reductions in the thal amus and sensorimotor cortex were not significant (p > 0.05). There were similar diminutions for the memory condition, which did not differ signifi cantly from the group differences for the baseline condition.
A mixed repeated measures multivariate analysis of variance (MAN OVA) was used to determine if the baseline and memory conditions differentially affected the control and Alzheimer group lateral asymmetries for the set of six homologous ROls. Lateral asymmetries of metabolic activity across homologous right (R) and left (L) regions were cal culated according to the following formula: H(R -L)/(R + L)] x lOO}. A significant interaction be tween the presence or absence of disease and con dition was found (F(6,7) = 5.62, P = 0.02), and only the temporal lobe demonstrated a significant inter action effect when all samples were tested individu ally using post-hoc univariate mixed repeated mea sures analyses of variance (F(1,12) = 12.46, p = 0.004). The controls, on the average, favored the right during both conditions, but were less disposed toward the right during the memory condition (mean lateral asymmetry 1.24 ± 2.9 for baseline and 0.87 ± 3.4 for memory). For the Alzheimer group, the mean lateral asymmetry favored the left temporal lobe during the baseline condition ( -2,82 ± 7.8) and the right during the memory condition (2.37 ± 8.5). There was no significant group effect on lateral asymmetry for the set of regional samples (F(6.7) = 0.76, p > 0.05), although a significant con dition effect was found (F(6,7) = 3.87, P = 0.05). Again, upon post-hoc F test follow-ups, only the temporal lobe reached significance (F(I,12) = 9.35, p = 0.0 1). A separate one-way MANOVA indi cated that there was no significant group differ ence for the set of mean lateral asymmetries at baseline (F(6,7) = 1.5 1, p > 0.05). Repeated mea sures MANOVAs were also performed to deter mine if either group, when tested separately, showed evidence of cognitive activation. The con-trol group did demonstrate a significant difference in lateral asymmetry between the baseline and memory conditions for the composite set of homol ogous ROIs (F(6.1) = 1624.0, P < 0.02), though none of the individual regions reached significance on follow-up with univariate repeated measures analyses of variance (p > 0.05). The Alzheimer group repeated measures MAN OVA for the set of homologous ROIs did not show a significant differ ence in lateral asymmetries for the two conditions (F(6.1) = 17.4, P > 0.05). These results indicate that although the control group did show evidence of cognitive activation for the regions studied when examined as a set, neither group demonstrated sig nificant differences in the individual regional mean lateral asymmetries between the baseline and memory conditions. However, when the two groups were tested relative to each other in a mixed design, the baseline and memory conditions af fected the temporal lobe lateral asymmetries of metabolic activity for the Alzheimer subjects and controls differently.
We also examined the shift of metabolic activity across homologous right and left regions during the memory condition relative to baseline according to the following formula: Shift = (lateral asymmetry for memory -lateral asymmetry for baseline). For the temporal lobes during the memory condition relative to baseline, all 7 Alzheimer patients showed a shift to the right, and 5 of the 7 controls showed a shift to the left. This result is statistically significant using Fisher's exact test (p < 0.025), though the outcome may have been due to chance as a result of performing multiple Fisher's tests. However, a significant group difference in mean shift of activity for the set of 6 lateral asymmetry differences using a one-way MAN OVA (F(6,7) = 5.62, p = 0.02) was also found, and again, only the temporal lobe shift for the Alzheimer group (mean shift = 5. 19 ± 3.8) differed significantly from con trols (mean shift = -0.37 ± 1.6) when tested using post-hoc F tests (F(l,12) = 12.46, P = 0.004). Fur thermore, the magnitude of the shift in the temporal lobes correlated significantly with the subject's ODS (r = 0.66, p < 0.02; see Fig. I) . The hemi spheric, frontal, parietal, sensorimotor, and tha lamic samples did not show any metabolic evidence of the memory challenge, that is, there were no sig nificant group differences in asymmetry shifts and no significant correlations between shift and ODS.
DISCUSSION
The significant decrement in glucose metabolic rates for the Alzheimer subjects compared to age matched controls is consistent with our earlier J Cereb Blood Flow Metab, Vol. 7, No.2, 1987 studies (Ferris et aI., 1980; de Leon et aI., 1983) and those of others (Benson et aI., 1983) . However, the similar diminution in frontal, temporal, and parietal activity found in the present study is in disagree ment with the more marked decreases found in the parietotemporal area relative to frontal lobe sam ples reported by other investigators (Chase et aI., 1983; Friedland et aI., 1983) . This discrepancy may be due to differences in patient severity of cognitive dysfunction. It is possible that our Alzheimer sub jects were relatively more demented than patients used by Friedland et al. (1983) . That study included six mildly impaired and four moderately-to-se verely impaired patients, whereas our group con sisted of two mildly impaired and five moderately severe Alzheimer patients. Other study differences include inconsistent procedures for identifying met abolic anatomy. Some groups have used standard ized atlases or the PET scan alone to define re gional activity. We believe such procedures in the absence of specific anatomic information from given patients may contribute to the discrepancies in results between studies. Interpretation of study results across groups has been further complicated by different ways of reporting results. For example, ratio data have been presented by some groups, whereas absolute metabolic rates have been re ported by other groups, including our own.
Consistent with other PET studies that have ex amined metabolic lateral asymmetries in resting Alzheimer patients (Benson et aI., 1983; Friedland et aI., 1983; Haxby et aI., 1986) , the present study also did not find a statistically significant direc tional preference for glucose use. However, we did find that the baseline and memory conditions af fected the temporal lobe lateral asymmetries of the Alzheimer and control groups differently. Our dem onstration that Alzheimer patients show a shift rel ative to baseline of temporal lobe activity to the right, rather than to the left as in controls, during the memory task is the first indication of a differen tially asymmetric response to activation. Specifi cally, we find direct evidence for an abnormal tem poral lobe metabolic response that is related to im paired performance during a verbal memory task. The magnitude of this relative change in the Alz heimer group was more than 10 times larger than the changes associated with memory activation in the normal group. Alternatively, the metabolic shift toward the right hemisphere in the Alzheimer pa tients relative to controls may represent a response to the novel aspects of seeing words flashed on the monitor, rather than poor memory processing (Goldberg and Costa, 198 1) . As Alzheimer subjects were unable to recognize repeated items above a chance level, it is also possible that these metabolic findings may reflect a lack of memory processing. However, demented subjects were participating in the task; they responded to the majority of items, and all seven patients showed a right shift in meta bolic activity. Further studies with simple para digms that permit a more accurate performance in the Alzheimer group will be necessary in order to identify a potential metabolic response as patho logic. Nevertheless, the differential metabolic shift suggests that cognitive tasks may provide a more sensitive PET probe for Alzheimer's disease.
